Markets:U.S & Europe

Particulars     19th  Feb. Chg Chg(%)
Nasdaq 13,874.46 9.1 0.07
Dow 31,494.32 0.98 0.03
FTSE 6,624.02 6.87 0.1
CAC 5,773.55 45.22 0.79
DAX 13,993.23 106.3 0.77
Dow Fut.* 31,479.00 45 0.14

*As per 22nd February

Asian markets:

Particulars       22nd Feb Chg Chg(%)
SGX Nifty 14,975.00 -19.5 -0.13
Nikkei 30,250.83 232.91 0.78
Straits Times 2,881.85 1.21 0.04
Hang Seng 30,753.36 108.63 0.35
Shanghai     3,703.40 7.23 0.2


ADR Watch:

Particulars                  19th Feb. Chg Chg(%)
Dr Reddy 63.25 0.53 0.85
HDFC Bank 82.71 1.26 1.55
ICICI Bank 17.39 -0.19 -1.08
Infosys 17.94 0.11 0.62
Tata Motor 21.43 -0.44 -2.01
Wipro 6.56 -0.02 -0.3


Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 72.56         0.00
Brent 62.77          1.01
Gold 1782.95          0.30
Silver 27.58          1.20



Particulars 19th Feb       18th  Feb
FIIs      119         903
DIIs    -1175       -1217


View on market: Stay Cautious, be with quality business:

Asian equities have opened higher to start the new week on a positive note. The bond selloff however, continued as treasury yields rose and sovereign debt fell in Australia and New Zealand. Benchmark indices in Japan outperformed while those in South Korea also advanced. Oil prices rose, Bitcoin trades lower this morning after notching another record over the weekend while Copper rose to the highest since September 2011. The Singapore-traded SGX Nifty, an early indicator of the Nifty 50 Index’s performance in India, down -0.13% to 14,975.00 as of 8:10 a.m.

Key Data/ Action, Result and Board meeting to watch

Major economic Data:

  • INR: Infrastructure Output (YoY) (Jan) on 26th February,2021
  • INR: GDP Quarterly (YoY) (Q3), on 26th February,2021

Fund View:

Motilal Oswal On Ambuja Cements Maintains Neutral rating Price target raised to Rs 275 from Rs 250 Remain neutral due to weak growth visibility beyond CY22 MSA with ACC has resulted in cost savings of Rs 250 crore and boosted PBT by 5% in CY20 Capacity expansion to improve near-term volumes Offer 10% holding company discount for its stake in ACC.

Emkay On Bharat Forge

Maintains buy rating Price target of Rs 760 CY21 demand outlook provided by 21 entities provides a positive read-through for Bharat Forge HCV segment is likely to rebound strongly in CY21 across regions Global and domestic PV segments are likely to witness a strong rebound driven by better macros and low channel inventory Expect revenue to grow 46% in FY22E driven by  a strong rebound in automotive and industrial segments Significant potential for segments like defence, aerospace, E-mobility and railways in the medium-term.

Emkay On Jubilant Foodworks Maintains buy rating Price target of Rs 2,750 New acquisition looks inexpensive but the risks remain Acquisition gives Jubilant access to Domino’s franchise in new markets at attractive valuations, adverse currency movements and high interest rates in Turkey remain a risk An elongated expected turnaround can result in earnings dilution for Jubilant Do not expect any meaningful upside / downside to forecasts given the size of the acquisition

News Update:

Adani Ports & SEZ: Incorporates wholly-owned subsidiary Aqua Desilting Pvt. Ltd. to carry out business of dredging, desiltation and sale / disposal of such desilted material from sea, river, dams and other water bodies.

Torrent Power: Emerges highest bidder for 51% privatisation of Power Distribution Company in Dadra & Nagar Haveli and Daman & Diu. With the addition of Dadra & Nagar Haveli (including Silvasa) and Daman & Diu, Torrent will distribute nearly 25 billion units to over 3.8 million customers and cater to a peak demand of over 5,000 MW.

PNB Housing Finance: Promoter PNB says that it will not participate in the company’s capital raising plans. The company will continue to pursue the proposed capital raising plans through permitted modes. The company had approved raising an amount of Rs 1,800 crore as tier-1 capital through QIP, preferential issue, rights issue or any other combination thereof on January 27, 2021.

NTPC: 5 MW, last part capacity for the 20 MW Auraiya Solar PV Project in Uttar Pradesh has been declared on Commercial Operation on February 20, 2021. The total installed capacity of NTPC and NTPC group now stands at 52,115 MW and 64,880 MW respectively.

Suven Life Sciences: Board of Directors approved issuance of 1.81 crore fully convertible warrants on a preferential basis to the promoter / promoter group. The price at which the warrants will be issued shall be determined later.

Tata Consumer Products: Has successfully completed the acquisition of 100% shares in Kottaram Agro Foods. Consequently, Kottaram Agro Foods has now become a wholly-owned subsidiary of the company.

Jubilant Foodworks: A wholly owned subsidiary of the company, Jubilant Foodworks Netherlands B.V., has entered into a purchase agreement with Turkish Private Equity Fund II L.P. to fully acquire Fides Food Systems Coöperatief U.A. which holds 32.81% equity shares in DP Eurasia N.V. The cost of acquisition is approximately 24.80 million pounds. The company has also executed the Purchase Agreement as guarantor in connection with the investment obligations of Jubilant Foodworks Netherlands B.V.

Source: MoneyControl, Business Standard, Bloomberg,Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting , or e-mailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.